Ion Beam Applications SA
XBRU:IBAB

Watchlist Manager
Ion Beam Applications SA Logo
Ion Beam Applications SA
XBRU:IBAB
Watchlist
Price: 11.72 EUR -0.68% Market Closed
Market Cap: 354.9m EUR

Net Margin
Ion Beam Applications SA

1.9%
Current
0%
Average
1.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
1.9%
=
Net Income
9.3m
/
Revenue
498.2m

Net Margin Across Competitors

Ion Beam Applications SA
Glance View

Market Cap
344m EUR
Industry
Health Care

Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. The company is headquartered in Louvain-La-Neuve, Brabant-Wallon. IBA is also active in the sterilization and ionization field. The firm operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.

IBAB Intrinsic Value
21.74 EUR
Undervaluation 46%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
1.9%
=
Net Income
9.3m
/
Revenue
498.2m
What is the Net Margin of Ion Beam Applications SA?

Based on Ion Beam Applications SA's most recent financial statements, the company has Net Margin of 1.9%.

Back to Top